This inventor holds 2 USPTO granted patents and 12 published patent applications and 2 EPO patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Masatoshi Takuwa: Innovator in Benzazepine Derivatives
Introduction
Masatoshi Takuwa is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on benzazepine derivatives. With a total of 2 patents, Takuwa's innovations have the potential to impact medical treatments significantly.
Latest Patents
Takuwa's latest patents focus on novel benzazepine compounds that exhibit vasopressin V and V antagonisms. These compounds, described by a specific formula, are designed for various medical applications. The formula includes components such as optionally substituted Calkyl and hydrocarbon rings, which may have at least one substituent. This innovative approach aims to enhance therapeutic options in the medical field.
Career Highlights
Masatoshi Takuwa is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to exploring new chemical compounds that can lead to improved medical therapies.
Collaborations
Takuwa collaborates with notable colleagues, including Hideto Fujiwara and Taiki Hanari. These partnerships foster a dynamic research environment that encourages innovation and the sharing of ideas.
Conclusion
Masatoshi Takuwa's contributions to the field of medicinal chemistry, particularly through his work on benzazepine derivatives, highlight his role as a key inventor in the industry. His ongoing research promises to pave the way for new medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
